BCCI has taken strict action against the young opening batsman Prithvi Shaw for doping violation. He will not be seen on the pitch till November 15, 2019, due to his 8-month suspension.
According to the statement given by the cricket board, Shaw was consuming a prohibited substance that is usually found in cough syrups.
Also Read: CCD Founder, VG Siddhartha Dead, Body Recovered From Nethravathi River
Via: News 18
The cricketer gave his urine samples during the Syed Mushtaq Ali trophy on February 22, 2019, in Indore. The samples exposed the presence of a substance named Terbutaline. The BCCI said:
“Shaw had provided a urine sample as part of the BCCI’s anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore. His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.”
Shaw defended himself saying that the presence was because he took cough syrup. BBCI was convinced with the answer and hence suspended him only for 8 months. BCCI said:
“The BCCI is satisfied with Shaw’s explanation that he had taken Terbutaline inadvertently to treat a Respiratory Tract Infection and not as a performance-enhancing drug. Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr. Shaw’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of eight months should apply, together with the disqualification of certain results.”